Bimi International Medical Inc Revenue Growth Rates (BIMI), Current and Historic Growth - CSIMarket
CSIMarket
 


Bimi International Medical Inc   (NASDAQ: BIMI)
 

BIMI's Revenue Growth by Quarter and Year

Bimi International Medical Inc 's Revenue results by quarter and year




BIMI Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter December -
3rd Quarter September 2.52
2nd Quarter June 5.56
1st Quarter March 3.20
FY 11.28

BIMIs Annual Revenue
Bimi International Medical Inc 's Revenue in the fiscal year 2022 $ 11.83 millions
Bimi International Medical Inc 's Revenue in the fiscal year 2021 $ 27.08 millions
Bimi International Medical Inc 's Revenue in the fiscal year 2020 $ 12.84 millions
Bimi International Medical Inc 's Revenue in the fiscal year 2019 $ 0.16 millions
Bimi International Medical Inc 's Revenue in the fiscal year 2018 $ 6.54 millions




BIMI Revenue third quarter 2023 Y/Y Growth Comment
Bimi International Medical Inc reported drop in Revenue in the third quarter 2023 by -48.82% to $ 2.52 millions, from the same quarter in 2022.
The fall in the third quarter 2023 Bimi International Medical Inc 's Revenue compares unfavorably to the Company's average Revenue jump of 70.25%.

Looking into third quarter 2023 results within Pharmacy Services & Retail Drugstore industry 14 other companies have achieved higher Revenue growth. While Bimi International Medical Inc ' s Revenue meltdown of -48.82% ranks overall at the positon no. 4103 in the third quarter 2023.




BIMI Revenue ( Y/Y Growth %) 2023
2022 2021 2020
4th Quarter December - - -66.13 % -
3rd Quarter September -48.82 % -64.22 % 345.95 % 1371.43 %
2nd Quarter June 96.47 % -69.44 % 144.33 % 1048.48 %
1st Quarter March 18.08 % 24.88 % 404.65 % -25.86 %
FY   - -81.4 % 110.65 % -

Financial Statements
Bimi International Medical Inc 's third quarter 2023 Revenue $ 2.52 millions BIMI's Income Statement
Bimi International Medical Inc 's third quarter 2022 Revenue $ 4.93 millions Quarterly BIMI's Income Statement


BIMI Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
4th Quarter December - - -86.36 % 79.61 %
3rd Quarter September -54.62 % 74.2 % 48.81 % -18.47 %
2nd Quarter June 73.75 % 4.43 % 326.73 % 781.4 %
1st Quarter March - 44.15 % -60.9 % -
FY (Year on Year)   - -81.4 % 110.65 % -




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #15
Retail Sector #205
Overall #4103

Revenue Y/Y Growth Statistics
High Average Low
1383.24 % 70.25 % -85.8 %
(Mar 31 2021)   (Mar 31 2020)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #15
Retail Sector #205
Overall #4103
Revenue Y/Y Growth Statistics
High Average Low
1383.24 % 70.25 % -85.8 %
(Mar 31 2021)   (Mar 31 2020)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Bimi International Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
787.99 % 50.33 % -96.84 %
(Jun 30 2020)  


BIMI's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Bimi International Medical Inc disclosed fall in Revenue from the second quarter by -54.62% to $ 2.52 millions, from $ 5.56 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2023 Revenue, this plainly could not be substantial to rescue Pharmacy Services & Retail Drugstore's company achievement, Most analysts pointed out.

Within Pharmacy Services & Retail Drugstore industry 15 other companies have achieved higher Revenue quarter on quarter growth. While Bimi International Medical Inc 's Revenue growth quarter on quarter, overall rank is 4342.


Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #16
Retail Sector #209
Overall #4342
Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #16
Retail Sector #209
Overall #4342
Revenue Q/Q Growth Statistics
High Average Low
787.99 % 50.33 % -96.84 %
(Jun 30 2020)  


BIMI's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Bimi International Medical Inc disclosed fall in Revenue from the second quarter by -54.62% to $ 2.52 millions, from $ 5.56 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2023 Revenue, this plainly could not be substantial to rescue Pharmacy Services & Retail Drugstore's company achievement, Most analysts pointed out.

Within Pharmacy Services & Retail Drugstore industry 15 other companies have achieved higher Revenue quarter on quarter growth. While Bimi International Medical Inc 's Revenue growth quarter on quarter, overall rank is 4342.


Bimi International Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 5.85 $ 8.26 $ 5.53 $ 5.04 $ 12.35
Y / Y Revenue Growth (TTM) -52.67 % -61.05 % -79.99 % -81.37 % -59.83 %
Year on Year Revenue Growth Overall Ranking # 4032 # 0 # 2 # 6 # 0
Seqeuential Revenue Change (TTM) -29.18 % 49.36 % 9.57 % -59.16 % -41.72 %
Seq. Revenue Growth (TTM) Overall Ranking # 3894 # 0 # 2005 # 1242 # 0


Cumulative Revenue growth Comment
Bimi International Medical Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2023. If the fiscal year would end in Sep 30 2023, Bimi International Medical Inc 's annual Revenue drop would be -52.67% year on year to $6 millions.

In the Retail sector 207 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 4032.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 12
Retail Sector # 208
Overall # 4032

Revenue TTM Y/Y Growth Statistics
High Average Low
236731.6 %
5327.22 %
-99.91 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 200
S&P 500 # 3894
Cumulative Revenue growth Comment
Bimi International Medical Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2023. If the fiscal year would end in Sep 30 2023, Bimi International Medical Inc 's annual Revenue drop would be -52.67% year on year to $6 millions.

In the Retail sector 207 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 4032.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 12
Retail Sector # 208
Overall # 4032

Revenue TTM Y/Y Growth Statistics
High Average Low
236731.6 %
5327.22 %
-99.91 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 200
S&P 500 # 3894




Other Revenue Growth
Pharmacy Services & Retail Drugstore Industry Revenue Growth Trends and Statistics
Retail Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BIMI's Revenue Growth Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2023 within Retail SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Qvc inc -1.04%$ -1.037 millions
Herbalife Ltd -1.08%$ -1.081 millions
Domino s Pizza Inc -3.86%$ -3.859 millions
Revolve Group Inc -4.27%$ -4.272 millions
Sally Beauty Holdings Inc -4.34%$ -4.338 millions
Suburban Propane Partners Lp-4.64%$ -4.644 millions
Alliance Entertainment Holding Corporation-5.00%$ -5.005 millions
Asbury Automotive Group Inc -5.17%$ -5.166 millions
Murphy Usa Inc -6.41%$ -6.405 millions
Hf Foods Group Inc -6.58%$ -6.580 millions
Therealreal Inc -6.75%$ -6.749 millions
Camping World Holdings Inc -6.79%$ -6.794 millions
Scansource Inc -7.20%$ -7.205 millions
Nu Skin Enterprises Inc -7.35%$ -7.352 millions
The Odp Corporation-7.50%$ -7.505 millions
Pool Corporation-8.72%$ -8.725 millions
Cdw Corp-9.46%$ -9.457 millions
Qvc Group Inc -9.66%$ -9.657 millions
Blue Apron Holdings Inc -9.91%$ -9.908 millions
A k a Brands Holding Corp -10.17%$ -10.174 millions
Insight Enterprises Inc -10.59%$ -10.590 millions
Pc Connection Inc -10.67%$ -10.675 millions
1stdibs com Inc -11.33%$ -11.334 millions
Unrivaled Brands Inc -11.41%$ -11.408 millions
Bark Inc -14.72%$ -14.722 millions
Lazydays Holdings Inc -15.97%$ -15.975 millions
Carvana Co -18.10%$ -18.104 millions
Party City Holdco Inc -18.89%$ -18.889 millions
Ll Flooring Holdings Inc -19.83%$ -19.832 millions
Haverty Furniture Companies Inc-19.99%$ -19.994 millions


About Bimi International Medical Inc Revenue Growth Rates (BIMI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Bimi International Medical Inc (CIK 1213660).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-23-096651
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Bimi International Medical Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.